vs

Side-by-side financial comparison of Ovid Therapeutics Inc. (OVID) and SUI Group Holdings Ltd. (SUIG). Click either name above to swap in a different company.

SUI Group Holdings Ltd. is the larger business by last-quarter revenue ($1.0M vs $718.0K, roughly 1.4× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs 42.6%).

The Sui Southern Gas Company (SSGC), (Urdu: سوئی سدرن گیس کمپنی) formerly known as Sui Gas Transmission Company Limited, is a Pakistani state-owned natural gas supply company based in Karachi, Pakistan.

OVID vs SUIG — Head-to-Head

Bigger by revenue
SUIG
SUIG
1.4× larger
SUIG
$1.0M
$718.0K
OVID
Growing faster (revenue YoY)
OVID
OVID
+802.1% gap
OVID
844.7%
42.6%
SUIG

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
OVID
OVID
SUIG
SUIG
Revenue
$718.0K
$1.0M
Net Profit
$-44.3M
Gross Margin
Operating Margin
-6278.7%
Net Margin
-4365.8%
Revenue YoY
844.7%
42.6%
Net Profit YoY
204.4%
-9644.8%
EPS (diluted)
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OVID
OVID
SUIG
SUIG
Q4 25
$718.0K
Q3 25
$132.0K
$1.0M
Q2 25
$6.3M
Q1 25
$130.0K
Q4 24
$76.0K
Q3 24
$173.0K
$711.0K
Q2 24
$169.0K
Q1 24
$148.0K
Net Profit
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
$-12.2M
$-44.3M
Q2 25
$-4.7M
Q1 25
$-10.2M
Q4 24
Q3 24
$-14.0M
$463.8K
Q2 24
$8.5M
Q1 24
$-11.7M
Operating Margin
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
-9487.1%
-6278.7%
Q2 25
-80.9%
Q1 25
-9653.8%
Q4 24
Q3 24
-7645.1%
82.9%
Q2 24
-12140.2%
Q1 24
-11768.2%
Net Margin
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
-9210.6%
-4365.8%
Q2 25
-74.7%
Q1 25
-7873.1%
Q4 24
Q3 24
-8096.0%
65.2%
Q2 24
5042.0%
Q1 24
-7901.4%
EPS (diluted)
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
$-0.72
Q2 25
Q1 25
Q4 24
Q3 24
$-0.20
$0.07
Q2 24
$0.12
Q1 24
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OVID
OVID
SUIG
SUIG
Cash + ST InvestmentsLiquidity on hand
$13.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$130.7M
$405.1M
Total Assets
$150.9M
$429.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OVID
OVID
SUIG
SUIG
Q4 25
$13.2M
Q3 25
$20.6M
Q2 25
$28.4M
Q1 25
$21.1M
Q4 24
$26.3M
Q3 24
$15.0M
Q2 24
$29.7M
Q1 24
$30.8M
Stockholders' Equity
OVID
OVID
SUIG
SUIG
Q4 25
$130.7M
Q3 25
$44.7M
$405.1M
Q2 25
$55.8M
Q1 25
$59.3M
Q4 24
$68.2M
Q3 24
$76.3M
$19.8M
Q2 24
$88.9M
Q1 24
$78.3M
Total Assets
OVID
OVID
SUIG
SUIG
Q4 25
$150.9M
Q3 25
$63.8M
$429.1M
Q2 25
$77.4M
Q1 25
$81.7M
Q4 24
$92.2M
Q3 24
$102.7M
$20.3M
Q2 24
$118.1M
Q1 24
$131.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OVID
OVID
SUIG
SUIG
Operating Cash FlowLast quarter
$-38.3M
$2.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OVID
OVID
SUIG
SUIG
Q4 25
$-38.3M
Q3 25
$-12.9M
$2.1M
Q2 25
$-4.8M
Q1 25
$-10.3M
Q4 24
$-56.0M
Q3 24
$-15.0M
$-3.8M
Q2 24
$-14.3M
Q1 24
$-16.7M
Free Cash Flow
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-56.0M
Q3 24
$-15.0M
Q2 24
$-14.3M
Q1 24
$-16.7M
FCF Margin
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-73719.7%
Q3 24
-8676.9%
Q2 24
-8455.0%
Q1 24
-11287.2%
Capex Intensity
OVID
OVID
SUIG
SUIG
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
93.4%
Q3 24
2.3%
Q2 24
20.1%
Q1 24
12.8%
Cash Conversion
OVID
OVID
SUIG
SUIG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-8.19×
Q2 24
-1.67×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons